AUTL

Autolus Therapeutics
AUTL

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$9.5
469% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Emily Bodnar
100% 1-yr AUTL win rate
17 Feb ‘26 13 days ago
Needham
Needham
Gil Blum
63% 1-yr AUTL win rate
12 Jan ‘26 1 month ago